Community-reported Aranesp side effects:
heart attack and atrial fibrillation 2008-08-23 08:22:06
Add Your Side Effect to the Community Database
Help Community - Describe Your Aranesp Side Effect Episode
Have You dealt with a Aranesp side effect? Share your experience
Review Aranesp Safety Reports submitted to FDA
Total Aranesp reports: 389.Aranesp FDA safety alerts: 2005 2006 2007 2008 .
Reported deaths: 41 Reported hospitalizations: 179.
Take Aranesp Side Effects Survey, Discuss Aranesp with others
FDA Reported Aranesp Side Effects: aplasia pure red cell, haemoglobin decreased, therapeutic response decreased, fatigue, dyspnoea, asthenia, bone marrow failure, anti-erythropoietin antibody positive, nausea, thrombocytopenia, headache.
More About Aranesp.
If you have questions about Aranesp, you can ask a Health Expert or Ask Patient Community about Aranesp.
Showing 1-100 of 389 Next >
Aranesp Side Effects Report #5313883-8Health Professional from UNITED STATES reported ARANESP problem on Apr 23, 2007. Male patient, 61 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, nephrogenic fibrosing dermopathy, nephrotic syndrome. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5315358-9
ARANESP problem was reported by a Physician from UNITED STATES on Apr 24, 2007. Male patient, weighting 180.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, alanine aminotransferase increased, anaemia, aplasia pure red cell, aspartate aminotransferase increased, asthenia, atrial fibrillation, burns second degree, candiduria. ARANESP dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ACTONEL, ALBUTEROL, ALDACTONE, ALLOPURINOL, ASPIRIN, BECONASE AQUA, BUMEX. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5316530-4
Health Professional from AUSTRALIA reported ARANESP problem on Apr 26, 2007. Female patient, weighting 110.2 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, arteriovenous fistula operation, dyspnoea, fatigue, iron deficiency, lethargy. ARANESP dosage: unknown. During the same period patient was treated with CALTRATE, LOSEC, DILANTIN, ROCALTROL, MYLANTA. Patient recovered.
Aranesp Side Effects Report #5316606-1
ARANESP problem was reported by a Physician from GERMANY on Apr 24, 2007. Male patient, 63 years of age, weighting 141.1 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5317145-4
Physician from BELGIUM reported ARANESP problem on Apr 25, 2007. Male patient, weighting 207.2 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5317153-3
ARANESP problem was reported by a Physician from GERMANY on Apr 27, 2007. Female patient, weighting 79.37 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-erythropoietin antibody positive, c-reactive protein increased, catheter related infection, haematoma, immunoglobulins increased, inflammation, iron metabolism disorder. ARANESP dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, ENALAPRIL, CALCIUM ACETATE, NEXIUM, METOCLOPRAMIDE, AZITHROMYCIN, AMLODIPINE, NOVAMINSULFON. Patient recovered.
Aranesp Side Effects Report #5317155-7
Health Professional from FRANCE reported ARANESP problem on Apr 25, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, angioedema, dehydration, eczema, escherichia sepsis, inflammation, nephritic syndrome. ARANESP dosage: unknown. During the same period patient was treated with EPREX, OFLOCET, NEURONTIN, NEXIUM, LASIX, SINTROM MITIS, LEVOTHYROXINE, BACTRIM. Patient was hospitalized. Patient died on 11/06/2006.
Aranesp Side Effects Report #5319050-6
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Male patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: diverticulitis, weight decreased. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5320685-5
Physician from UNITED STATES reported ARANESP problem on May 01, 2007. Female patient, weighting 141.1 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, dyspnoea, hypotension, panic attack, pulmonary embolism, pulmonary hypertension, tachycardia. ARANESP dosage: unknown. During the same period patient was treated with DIFLUCAN, DECADRON, EMEND, ZOFRAN, ROXICET, TETRACYCLINE, HYDROCORTISONE, NYSTATIN. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5321559-6
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, weighting 130.1 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: chills, eye swelling, haemoglobin decreased, pyrexia, transfusion reaction. ARANESP dosage: unknown. During the same period patient was treated with LEUKERAN. Patient recovered.
Aranesp Side Effects Report #5322145-4
Physician from UNITED STATES reported ARANESP problem on May 03, 2007. Female patient, 83 years of age, weighting 88.18 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke. ARANESP dosage: unknown. During the same period patient was treated with EXJADE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5322147-8
ARANESP problem was reported by a Physician from on May 04, 2007. Male patient, 72 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, hospitalisation. ARANESP dosage: unknown. During the same period patient was treated with IRON DEXTRAN. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5323552-6
Health Professional from FRANCE reported ARANESP problem on May 04, 2007. Female patient, 71 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, angioedema, dehydration, eczema, escherichia sepsis, inflammation, nephritic syndrome. ARANESP dosage: unknown. During the same period patient was treated with OFLOCET, NEURONTIN, NEXIUM, SINTROM, LEVOTHYROXINE, INIPOMP, EPREX, LASIX. Patient was hospitalized. Patient died on 11/06/2006.
Aranesp Side Effects Report #5323557-5
ARANESP problem was reported by a Physician from GERMANY on May 04, 2007. Female patient, weighting 79.37 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-erythropoietin antibody positive, blood immunoglobulin g increased, c-reactive protein increased, catheter related infection, haematoma, immunoglobulins increased, inflammation. ARANESP dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, ENALAPRIL, CALCIUM ACETATE, NEXIUM, METOCLOPRAMIDE, AZITHROMYCIN, AMLODIPINE, NOVAMINSULFON. Patient recovered.
Aranesp Side Effects Report #5323580-0
Physician from FRANCE reported ARANESP problem on May 03, 2007. Male patient, 66 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypertension, overdose, thrombocytopenia. ARANESP dosage: unknown. During the same period patient was treated with METHOTREXATE, VINBLASTINE SULPHATE, ADRIAMYCIN PFS, CISPLATIN. Patient recovered.
Aranesp Side Effects Report #5323957-3
ARANESP problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, weighting 135.0 lb, was diagnosed with anaemia, breast cancer metastatic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: dysphagia, gastroenteritis. ARANESP dosage: unknown. During the same period patient was treated with AVASTIN, GEMZAR, SUTENT, FOSAMAX, CORDARONE, ELAVIL, TENORMIN, LIPITOR. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5324048-8
Consumer or non-health professional from UNITED STATES reported ARANESP problem on May 09, 2007. Female patient, weighting 120.0 lb, was diagnosed with haemoglobin decreased and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, asthenia, communication disorder, dizziness, fall, haemoglobin decreased, myocardial infarction, speech disorder. ARANESP dosage: unknown. Patient died on 03/16/2006.
Aranesp Side Effects Report #5326817-7
ARANESP problem was reported by a Physician from BELGIUM on May 07, 2007. Male patient, weighting 207.2 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5328493-6
Health Professional from UNITED STATES reported ARANESP problem on May 10, 2007. Female patient, weighting 165.3 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: herpes dermatitis, vasculitis. ARANESP dosage: unknown. During the same period patient was treated with TRICOR, ZOLOFT, ASPIRIN, SYNTHROID, FLONASE, AMITRIPTYLINE, ALTACE, PREDNISONE. Patient recovered.
Aranesp Side Effects Report #5328516-4
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Male patient, weighting 220.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hospitalisation. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5328522-X
Health Professional from SPAIN reported ARANESP problem on May 09, 2007. Male patient, 63 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: angina pectoris. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5329774-2
ARANESP problem was reported by a Physician from POLAND on May 09, 2007. Female patient, 31 years of age, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, caesarean section, labile blood pressure, premature labour, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with FOLIC ACID, CALCIUM CHLORIDE, ASCORBIC ACID, VITAMIN D. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5330233-1
Physician from POLAND reported ARANESP problem on May 09, 2007. Female patient, 33 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypertension, hypervolaemia, metabolic acidosis, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with METHYLDOPA. Patient recovered.
Aranesp Side Effects Report #5330480-9
ARANESP problem was reported by a Physician from UNITED STATES on May 11, 2007. Male patient, weighting 225.3 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: cardiac failure, deep vein thrombosis, nutritional condition abnormal, pleural effusion, pneumonia, pseudomonas infection, pulmonary embolism, rash erythematous. ARANESP dosage: unknown. During the same period patient was treated with PROCRIT, BUMEX, COUMADIN, TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5330491-3
Health Professional from UNITED STATES reported ARANESP problem on May 11, 2007. Male patient, weighting 173.5 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, COZAAR, HUMALOG, LANTUS, METOPROLOL SUCCINATE, NORVASC, PREVACID, RENAGEL. Patient recovered.
Aranesp Side Effects Report #5332611-3
ARANESP problem was reported by a Physician from SPAIN on May 14, 2007. Male patient, 43 years of age, weighting 141.1 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with EPOETIN ALFA, CALCIUM CHLORIDE, RENAGEL, CARVEDILOL, ADALAT, BECOZYME, PREDNISONE, CYCLOSPORINE. Patient recovered.
Aranesp Side Effects Report #5333246-9
Health Professional from UNITED STATES reported ARANESP problem on May 18, 2007. Female patient, weighting 165.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: rash, vasculitis. ARANESP dosage: unknown. During the same period patient was treated with TRICOR, ZOLOFT, ASPIRIN, SYNTHROID, FLONASE, AMITRIPTYLINE, ALTACE, PREDNISONE. Patient recovered.
Aranesp Side Effects Report #5333974-5
ARANESP problem was reported by a Health Professional from UNITED KINGDOM on May 15, 2007. Female patient, 45 years of age, weighting 165.3 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, thymoma. ARANESP dosage: unknown. During the same period patient was treated with EPREX, AZATHIOPRINE. Patient recovered.
Aranesp Side Effects Report #5336989-6
Physician from UNITED STATES reported ARANESP problem on May 22, 2007. Male patient, weighting 181.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow failure, hepatitis b antibody, leukocytosis. ARANESP dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, PLAVIX, METOPROLOL SUCCINATE, INSULIN, ALLOPURINOL, TEMAZEPAM, LISINOPRIL. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5339941-X
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 42 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, liver disorder, renal disorder, weight decreased. ARANESP dosage: unknown. Patient was hospitalized. Patient died on 11/01/2006.
Aranesp Side Effects Report #5341073-1
Physician from FRANCE reported ARANESP problem on May 22, 2007. Male patient, 22 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, haemoglobin decreased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5341074-3
ARANESP problem was reported by a Physician from GERMANY on May 22, 2007. Male patient, 40 years of age, was diagnosed with renal transplant and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with MYFORTIC. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5341090-1
Physician from FRANCE reported ARANESP problem on May 22, 2007. Male patient, 66 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: overdose, thrombocytopenia. ARANESP dosage: unknown. During the same period patient was treated with METHOTREXATE, VINBLASTINE SULPHATE, ADRIAMYCIN PFS, CISPLATIN, TRANDOLAPRIL, PLAVIX. Patient recovered.
Aranesp Side Effects Report #5341123-2
ARANESP problem was reported by a Physician from SPAIN on May 22, 2007. Male patient, 43 years of age, weighting 141.1 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with EPOETIN ALFA, CALCIUM CHLORIDE, RENAGEL, CARVEDILOL, ADALAT, BECOZYME. Patient recovered.
Aranesp Side Effects Report #5342665-6
Health Professional from FRANCE reported ARANESP problem on May 24, 2007. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: inflammation, lymphopenia, microcytic anaemia, pyrexia, skin ulcer. ARANESP dosage: unknown. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5346508-6
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Female patient, 42 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, ascites, asthenia, liver disorder, renal failure chronic, weight decreased. ARANESP dosage: unknown. Patient was hospitalized. Patient died on 11/01/2006.
Aranesp Side Effects Report #5346510-4
Physician from UNITED STATES reported ARANESP problem on May 29, 2007. Male patient, weighting 75.62 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, ocular icterus, pancytopenia, therapeutic response decreased, urine copper increased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5349052-5
ARANESP problem was reported by a Physician from FRANCE on May 23, 2007. Male patient, 22 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5351223-9
Physician from SWITZERLAND reported ARANESP problem on May 31, 2007. Female patient, 47 years of age, weighting 110.2 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia. ARANESP dosage: unknown. During the same period patient was treated with ASPIRIN, SELIPRAN, LOSARTAN POTASSIUM, TENORMIN, CELLCEPT, SANDIMMUNE, CEFPODOXIME PROXETIL, EFFEXOR. Patient recovered.
Aranesp Side Effects Report #5351269-0
ARANESP problem was reported by a Physician from GERMANY on May 31, 2007. Male patient, 63 years of age, weighting 213.8 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5351274-4
Physician from GERMANY reported ARANESP problem on May 31, 2007. Male patient, 72 years of age, weighting 211.6 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with BLOOD. Patient recovered.
Aranesp Side Effects Report #5351280-X
ARANESP problem was reported by a Health Professional from UNITED KINGDOM on May 30, 2007. Female patient, 45 years of age, weighting 165.3 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, thymoma. ARANESP dosage: unknown. During the same period patient was treated with EPREX, AZATHIOPRINE. Patient recovered.
Aranesp Side Effects Report #5351296-3
Physician from UNITED STATES reported ARANESP problem on May 31, 2007. Female patient, 83 years of age, weighting 88.18 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke. ARANESP dosage: unknown. During the same period patient was treated with EXJADE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5353927-0
ARANESP problem was reported by a Pharmacist from UNITED STATES on June 08, 2007. Female patient, 77 years of age, weighting 176.4 lb, was diagnosed with anaemia, renal failure and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, heparin-induced thrombocytopenia, hepatic function abnormal, laboratory test abnormal, myocardial infarction. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5356991-8
Health Professional from UNITED KINGDOM reported ARANESP problem on June 04, 2007. Male patient, 78 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: convulsion. ARANESP dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, LISINOPRIL, ISOSORBIDE MONONITRATE, ATORVASTATIN CALCIUM, FRUSEMIDE, ASPIRIN, CALCIUM CHLORIDE, HYDRALAZINE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5357001-9
ARANESP problem was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, weighting 198.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, duodenitis, haemoglobin decreased, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VENOFER. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5358757-1
Health Professional from UNITED STATES reported ARANESP problem on June 06, 2007. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: neutropenia, therapeutic response decreased, thrombocytopenia. ARANESP dosage: unknown. During the same period patient was treated with NEUPOGEN. Patient recovered.
Aranesp Side Effects Report #5360345-8
ARANESP problem was reported by a Physician from FRANCE on June 06, 2007. Female patient, 35 years of age, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: amnesia, convulsion, fall, loss of consciousness. ARANESP dosage: unknown. During the same period patient was treated with MIMPARA, RENAGEL, ALFACALCIDOL, VENOFER. Patient was hospitalized and became disabled. Patient recovered.
Aranesp Side Effects Report #5360347-1
Physician from GERMANY reported ARANESP problem on June 08, 2007. Female patient, weighting 79.37 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-erythropoietin antibody positive, c-reactive protein increased, catheter related infection, haematoma, immunoglobulins increased, inflammation, iron metabolism disorder. ARANESP dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, ENALAPRIL MALEATE, CALCIUM ACETATE, NEXIUM, METOCLOPRAMIDE, AZITHROMYCIN, AMLODIPINE, NOVAMINSULFON. Patient recovered.
Aranesp Side Effects Report #5360358-6
ARANESP problem was reported by a Physician from BELGIUM on June 08, 2007. Male patient, weighting 137.1 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with ALLOPURINOL, ENALAPRIL MALEATE, COLECALCIFEROL, BICARBONATE, FLUOR, LIPITOR, SANDIMMUNE, CELLCEPT. Patient recovered.
Aranesp Side Effects Report #5360366-5
Physician from FRANCE reported ARANESP problem on June 06, 2007. Female patient, 35 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: convulsion, hypertension, hypertensive encephalopathy, status epilepticus. ARANESP dosage: unknown. During the same period patient was treated with IRBESARTAN, FOSINOPRIL, ALFACALCIDOL, LIOTHYRONINE, LEVOTHYROXINE, AMLODIPINE, PANTOPRAZOLE, ZOLPIDEM. Patient was hospitalized and became disabled. Patient recovered.
Aranesp Side Effects Report #5368634-8
ARANESP problem was reported by a Pharmacist from CANADA on June 14, 2007. Female patient, weighting 284.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: refractory anaemia. ARANESP dosage: unknown. During the same period patient was treated with MONOCOR, LASIX, CARDURA, DIOVAN, IMDUR, ASPIRIN, PLAVIX, PANTOPRAZOLE. Patient recovered.
Aranesp Side Effects Report #5368647-6
Physician from SWITZERLAND reported ARANESP problem on June 15, 2007. Female patient, weighting 154.3 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: metastasis, neoplasm recurrence. ARANESP dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, ROCALTROL, CONCOR, COZAAR, MARCUMAR, CLARITIN, ATORVASTATIN CALCIUM, DREISAVIT. Patient recovered.
Aranesp Side Effects Report #5368648-8
ARANESP problem was reported by a Physician from SWITZERLAND on June 14, 2007. Female patient, 47 years of age, weighting 110.2 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia. ARANESP dosage: unknown. During the same period patient was treated with ASPIRIN, SELIPRAN, LOSARTAN, TENORMIN, CELLCEPT, SANDIMMUNE, CEFPODOXIME PROXETIL, EFFEXOR. Patient recovered.
Aranesp Side Effects Report #5368649-X
Physician from SPAIN reported ARANESP problem on June 14, 2007. Male patient, 43 years of age, weighting 141.1 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with EPOETIN ALFA, CALCIUM CHLORIDE, RENAGEL, CARVEDILOL, ADALAT, BECOZYME. Patient recovered.
Aranesp Side Effects Report #5368650-6
ARANESP problem was reported by a Physician from UNITED KINGDOM on June 14, 2007. Male patient, weighting 198.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: duodenitis, haemoglobin decreased, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VENOFER. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5370322-9
Physician from UNITED STATES reported ARANESP problem on Nov 08, 2006. Female patient, weighting 171.1 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypertension, nausea. ARANESP dosage: unknown. During the same period patient was treated with CARDIZEM, CLONIDINE, LOPRESSOR, LOTENSIN, DIOVAN, LASIX, ASPIRIN, CATAPRES. Patient recovered.
Aranesp Side Effects Report #5370325-4
ARANESP problem was reported by a Physician from UNITED STATES on Nov 07, 2006. Female patient, weighting 135.1 lb, was diagnosed with myelodysplastic syndrome and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: arrhythmia, hypertension, malaise, no therapeutic response. ARANESP dosage: unknown. During the same period patient was treated with TOPROL, MICARDIS, GLUCOSAMINE, PREVACID, VITAMIN CAP. Patient recovered.
Aranesp Side Effects Report #5370329-1
Physician from UNITED STATES reported ARANESP problem on Nov 06, 2006. Female patient, weighting 132.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, parvovirus b19 serology positive. ARANESP dosage: unknown. During the same period patient was treated with TACROLIMUS, BICARBONATE, CALCIUM CARBONATE, CALCITRIOL, VYTORIN, ASPIRIN, PREDNISONE, CELLCEPT. Patient recovered.
Aranesp Side Effects Report #5370331-X
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Male patient, 87 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: sluggishness. ARANESP dosage: unknown. During the same period patient was treated with PLAVIX, PRANDIN, COREG, ISOSORBIDE DINITRATE, POTASSIUM ACETATE, FUROSEMIDE, LISINOPRIL. Patient recovered.
Aranesp Side Effects Report #5370332-1
Physician from UNITED STATES reported ARANESP problem on Nov 09, 2006. Male patient, weighting 167.1 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: back pain, chest pain, constipation, dermatitis, headache, hypersensitivity, protein total increased, pruritus, rash. ARANESP dosage: unknown. During the same period patient was treated with VELCADE, ANZEMET, COUMADIN, PERCOCET. Patient recovered.
Aranesp Side Effects Report #5370348-5
ARANESP problem was reported by a Health Professional from UNITED STATES on Nov 27, 2006. Male patient, weighting 158.1 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. ARANESP dosage: unknown. During the same period patient was treated with NEUPOGEN, NEULASTA, ADRIAMYCIN PFS, VINCRISTINE, CYTOXAN, MORPHINE, COLACE, NEXIUM. Patient died on 11/04/2006.
Aranesp Side Effects Report #5370351-5
Health Professional from UNITED STATES reported ARANESP problem on Nov 28, 2006. Male patient, 61 years of age, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with PHOSLO, FOLVITE, RENAGEL, CEPHULAC, DIGOXIN, CORDARONE, COMPAZINE. Patient recovered.
Aranesp Side Effects Report #5370353-9
ARANESP problem was reported by a Physician from UNITED STATES on Nov 29, 2006. Male patient, weighting 251.3 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: reticulocyte count decreased, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with RIBAVIRIN, PROCRIT, COZAAR, INSULIN, INSULIN LISPRO. Patient recovered.
Aranesp Side Effects Report #5370370-9
Health Professional from UNITED STATES reported ARANESP problem on Dec 15, 2006. Female patient, 80 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: injection site pain. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5370373-4
ARANESP problem was reported by a Physician from UNITED STATES on Dec 07, 2006. Female patient, weighting 232.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, vision blurred. ARANESP dosage: unknown. During the same period patient was treated with LIPITOR, ISOSORBIDE DINITRATE, VITAMIN CAP, TOPROL, HYDROCHLOROTHIAZIDE, BICARBONATE, LASIX, PRINIVIL. Patient recovered.
Aranesp Side Effects Report #5370378-3
Physician from UNITED STATES reported ARANESP problem on Dec 04, 2006. Female patient, weighting 113.1 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with RITUXAN, PRILOSEC, LOPID, METHOCARBAMOL, FIORICET, TYLENOL, CLARITIN, FOLIC ACID. Patient recovered.
Aranesp Side Effects Report #5370381-3
ARANESP problem was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 83 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: injection site bruising, injection site haemorrhage, injection site reaction. ARANESP dosage: unknown. During the same period patient was treated with DOCUSATE, DOXERCALCIFEROL, FAMOTIDINE, GLIPIZIDE, FLUNISOLIDE, HYDRALAZINE HYDROCHLORIDE, LISINOPRIL, LORATADINE. Patient recovered.
Aranesp Side Effects Report #5370391-6
Physician from UNITED STATES reported ARANESP problem on Jan 11, 2007. Female patient, 54 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: therapeutic response decreased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5370394-1
ARANESP problem was reported by a Physician from UNITED STATES on Jan 11, 2007. Male patient, 83 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: back pain, haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with VITAMIN B. Patient recovered.
Aranesp Side Effects Report #5370417-X
Consumer or non-health professional from UNITED STATES reported ARANESP problem on Jan 19, 2007. Female patient, weighting 116.2 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypersensitivity. ARANESP dosage: unknown. During the same period patient was treated with CARDURA, COZAAR, VERAPAMIL, PLAVIX. Patient recovered.
Aranesp Side Effects Report #5370460-0
ARANESP problem was reported by a Physician from on Mar 21, 2007. Female patient, weighting 204.1 lb, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, urticaria. ARANESP dosage: unknown. During the same period patient was treated with WELLBUTRIN, LEXAPRO, PREVACID, PENTASA, CRESTOR, SYNTHROID, GLUCOPHAGE, GLUCOTROL. Patient recovered.
Aranesp Side Effects Report #5370464-8
Physician from UNITED STATES reported ARANESP problem on Mar 09, 2007. Female patient, weighting 112.0 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia. ARANESP dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
Aranesp Side Effects Report #5370466-1
ARANESP problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, weighting 179.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: arthralgia, bronchitis, cough, dyspnoea, fatigue, joint swelling, pain in extremity. ARANESP dosage: unknown. During the same period patient was treated with LASIX. Patient recovered.
Aranesp Side Effects Report #5370467-3
Physician from UNITED STATES reported ARANESP problem on Mar 14, 2007. Male patient, weighting 150.6 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, fatigue. ARANESP dosage: unknown. During the same period patient was treated with FLOMAX, DILACOR, ASPIRIN, RHINOCORT, PRILOSEC, VITAMIN CAP. Patient recovered.
Aranesp Side Effects Report #5370479-X
ARANESP problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Male patient, weighting 211.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: rash erythematous. ARANESP dosage: unknown. During the same period patient was treated with NEORAL, PROPOXYPHENE NAPSYLATE W, CLOPIDOGREL BISULPHATE, HYDRALAZINE, ALLOPURINOL, COZAAR, FLOMAX, FUROSEMIDE. Patient recovered.
Aranesp Side Effects Report #5370484-3
Health Professional from UNITED STATES reported ARANESP problem on Mar 22, 2007. Male patient, 81 years of age, was diagnosed with myelodysplastic syndrome, anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia. ARANESP dosage: unknown. During the same period patient was treated with REVLIMID, DECADRON. Patient recovered.
Aranesp Side Effects Report #5371754-5
ARANESP problem was reported by a Health Professional from AUSTRALIA on June 18, 2007. Male patient, weighting 198.4 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: candidiasis, dermatitis allergic. ARANESP dosage: unknown. During the same period patient was treated with LASIX, MIXTARD. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5047821-2
Health Professional from FINLAND reported ARANESP problem on Dec 09, 2005. Female patient, weighting 105.8 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia. ARANESP dosage: unknown. During the same period patient was treated with MYFORTIC, CELLCEPT, COZAAR, ETALPHA, FURESIS, KALCIPOS, LESCOL, MEDROL. Patient recovered.
Aranesp Side Effects Report #5048708-1
ARANESP problem was reported by a Physician from SPAIN on May 15, 2006. Female patient, 25 years of age, weighting 83.78 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell. ARANESP dosage: unknown. During the same period patient was treated with AZATHIOPRINE, ENALAPRIL, PREDNISONE, ATORVASTATIN CALCIUM, CYANOCOBALAMIN, FERRO, AMLODIPINE, PROGRAF. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5050295-9
Physician from GERMANY reported ARANESP problem on June 30, 2006. Female patient, weighting 121.3 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anti-erythropoietin antibody, haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with INSULIN ACTRAPID, DREISAVIT, AMLODIPINE, POLYSTYRENE SULFONATE, CARVEDILOL, CALCIUM GLUCONATE, ASPIRIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5053671-3
ARANESP problem was reported by a Health Professional from FRANCE on July 04, 2006. Female patient, 80 years of age, weighting 88.18 lb, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. ARANESP dosage: unknown. During the same period patient was treated with CORTANCYL, VASTAREL, FUMAFER, ALKERAN. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5053736-6
Physician from UNITED STATES reported ARANESP problem on May 15, 2006. Male patient, weighting 55.12 lb, was diagnosed with renal failure chronic, dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: herpes zoster, lung disorder, myelodysplastic syndrome, pancytopenia, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with EPOGEN, NEXIUM, CLONIDINE, AZACITIDINE. Patient recovered.
Aranesp Side Effects Report #5057105-4
ARANESP problem was reported by a Physician from CANADA on Mar 22, 2006. Male patient, weighting 17.42 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood pressure increased, bone marrow failure, catheter related complication, cough, haemodialysis, indwelling catheter management, respiratory syncytial virus infection. ARANESP dosage: unknown. During the same period patient was treated with CALCITRIOL, FERROUS SULPHATE, CHLORIDE, RANITIDINE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5058753-8
Health Professional from UNITED STATES reported ARANESP problem on May 05, 2005. Female patient, weighting 176.4 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, myalgia. ARANESP dosage: unknown. During the same period patient was treated with EPOGEN, PROCRIT. Patient recovered.
Aranesp Side Effects Report #5061973-X
ARANESP problem was reported by a Pharmacist from UNITED STATES on July 14, 2006. Male patient, 44 years of age, weighting 346.1 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: inguinal mass. ARANESP dosage: unknown. During the same period patient was treated with VERAPAMIL, PROTONIX, REGLAN, NEPHROX, PERCOCET, MORPHINE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5061979-0
Physician from UNITED STATES reported ARANESP problem on June 23, 2006. Male patient, weighting 174.2 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: asthenia, blood pressure decreased, dyspnoea, fatigue, malaise, melaena, oedema, pneumonia, weight decreased. ARANESP dosage: unknown. During the same period patient was treated with ZOCOR. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5061987-X
ARANESP problem was reported by a Physician from GERMANY on June 08, 2006. Female patient, weighting 114.6 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, breast discomfort, treatment noncompliance, vaginal haemorrhage. ARANESP dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, CALCIUM ACETATE, CALCITRIOL, PREDNISOLONE, MADOPAR, RANITIDINE, CANDESARTAN CILEXETIL. Patient recovered.
Aranesp Side Effects Report #5064275-0
Physician from TAIWAN, PROVINCE OF CHINA reported ARANESP problem on July 14, 2006. Male patient, 80 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, anti-erythrocyte antibody negative. ARANESP dosage: unknown. During the same period patient was treated with EPREX. Patient recovered.
Aranesp Side Effects Report #5066594-0
ARANESP problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 16, 2005. Male patient, 58 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anti-erythropoietin antibody positive, aplasia pure red cell, haemodialysis, infection. ARANESP dosage: unknown. During the same period patient was treated with KETOVITE, WARFARIN, VENOFER. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5067699-0
Physician from UNITED STATES reported ARANESP problem on July 17, 2006. Female patient, weighting 214.3 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: anaemia, dizziness, hypoglycaemia, therapeutic response decreased. ARANESP dosage: unknown. During the same period patient was treated with MIRAPEX, ALLOPURINOL, PLAVIX, METOPROLOL, VYTORIN, IMDUR, TRAMADOL, SYNTHROID. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5071309-6
ARANESP problem was reported by a Physician from UNITED STATES on Dec 08, 2005. Male patient, weighting 156.5 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with NORVASC, ATENOLOL, ASPIRIN, PLAVIX, PHOSLO, NEPHRO, ZEMPLAR, VENOFER. Patient recovered.
Aranesp Side Effects Report #5071313-8
Health Professional from UNITED STATES reported ARANESP problem on Sept 27, 2005. Male patient, weighting 160.9 lb, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: porphyria, skin lesion. ARANESP dosage: unknown. During the same period patient was treated with SENSIPAR, ASPIRIN, AMLODIPINE, CALCIUM CARBONATE, DOXERCALCIFEROL, GLYBURIDE, NEPHRO, ISOSORBIDE MONONITRATE. Patient recovered.
Aranesp Side Effects Report #5071315-1
ARANESP problem was reported by a Physician from UNITED STATES on Nov 18, 2005. Female patient, 14 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: injection site pain, migraine, myalgia, nausea. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5071319-9
Physician from UNITED STATES reported ARANESP problem on Dec 16, 2005. Male patient, 64 years of age, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: therapeutic response decreased. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5071321-7
ARANESP problem was reported by a Health Professional from UNITED STATES on Dec 15, 2005. Female patient, weighting 121.3 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: iron deficiency, therapeutic response decreased, treatment noncompliance. ARANESP dosage: unknown. During the same period patient was treated with CELLCEPT, RABEPRAZOLE, ASPIRIN, BACTRIM, CALCIUM CARBONATE, NIFEREX, TACROLIMUS. Patient recovered.
Aranesp Side Effects Report #5071326-6
Physician from UNITED STATES reported ARANESP problem on Nov 09, 2005. Male patient, weighting 191.1 lb, was diagnosed with myelodysplastic syndrome and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: abscess, dermatitis, hypersensitivity, insomnia, oedema, pruritus, rash erythematous. ARANESP dosage: unknown. Patient recovered.
Aranesp Side Effects Report #5071327-8
ARANESP problem was reported by a Physician from UNITED STATES on Nov 02, 2005. Female patient, 83 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, epistaxis. ARANESP dosage: unknown. During the same period patient was treated with FOSAMAX, DIOVAN, VERAPAMIL, ALLOPURINOL, LOVASTATIN, NEXIUM, RANITIDINE, ALBUTEROL. Patient recovered.
Aranesp Side Effects Report #5071331-X
Health Professional from UNITED STATES reported ARANESP problem on Feb 03, 2006. Female patient, 46 years of age, was diagnosed with anaemia and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: convulsion. ARANESP dosage: unknown. During the same period patient was treated with DILANTIN. Patient recovered.
Aranesp Side Effects Report #5071338-2
ARANESP problem was reported by a Physician from UNITED STATES on Dec 19, 2005. Female patient, 89 years of age, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. ARANESP dosage: unknown. During the same period patient was treated with VENOFER. Patient recovered.
Showing 1-100 of 389 Next >
Drug Information: Darbepoetin Alfa Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a604022.html
(dar be poe' e tin)IMPORTANT WARNING:
| All patients:Darbepoetin alfa increases the risk of blood clots forming in or moving to the legs, lungs, or brain. Call your doctor immediately if you experience any of the following symptoms: pain, tenderness, redness, warmth, and/or swelling in the legs; shortness of breath; cough that won't go away or that brings up blood; chest pain; sudden trouble seeing in one or both eyes; sudden trouble speaking or understanding speech; sudden confusion; sudden weakness or numbness of an arm or leg (especially on one side of the body), or of the face; sudden trouble walking or loss of balance or coordination; sudden severe headache; or seizure.Using darbepoetin alfa increases the risk that you will develop a blood clot during or after surgery. Before you have surgery, tell your doctor that you are using darbepoetin alfa. Your doctor may prescribe an anticoagulant ('blood thinner') to help prevent blood clots from forming during or after surgery.Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to darbepoetin alfa. Your doctor may decrease your dose if the tests show that you are at high risk of experiencing serious side effects of darbepoetin alfa.Talk to your doctor about the risks of using darbepoetin alfa.Patients with chronic renal failure:Your doctor will adjust your dose of darbepoetin alfa so that your hemoglobin level (amount of a protein found in red blood cells) is between 10-12g/dL. If your hemoglobin level is higher than this, there is a greater risk that you will develop serious side effects including heart attack, stroke, heart failure, blood clots, and death. Call your doctor immediately if you experience any of the following symptoms: chest pain, squeezing pressure, or tightness; shortness of breath; nausea, lightheadedness, sweating, and other early signs of heart attack; discomfort or pain in the arms, shoulder, neck, jaw, or back; fast or irregular heartbeat; swelling of the hands, feet, or ankles; blue-grey coloring or darkening around mouth or nails; extreme tiredness or weakness; or fainting or loss of consciousness. If you are receiving hemodialysis (treatment in which the blood is passed through a filter to remove wastes that would normally be removed by the kidneys), you may develop a blood clot in your vascular access (place on your body where your blood is removed and returned during dialysis). Call your doctor right away if you think you have a blood clot in your vascular access.Cancer patients:In clinical studies, people with certain cancers who received darbepoetin alfa died sooner or experienced tumor growth or cancer that spread sooner than people who did not receive the medication. If you have cancer, there is a risk that your tumor will grow faster or you will die sooner if you receive darbepoetin alfa, even if your hemoglobin level is kept lower than 12g/dL. To decrease these risks, you should receive the lowest possible dose of darbepoetin alfa and you should only receive darbepoetin alfa while you are receiving chemotherapy. Treatment with darbepoetin alfa should be stopped when your course of chemotherapy ends. |
Why is this medication prescribed?
Darbepoetin alfa is used to treat anemia (a lower than normal number of red blood cells) in people with chronic kidney failure (condition in which the kidneys slowly and permanently stop working over a period of time). Darbepoetin alfa is also used to treat anemia caused by chemotherapy (medications to treat cancer). Darbepoetin alfa is in a class of medications called erythropoiesis-stimulating agents (ESAs). It works by causing the bone marrow (soft tissue inside the bones where blood is made) to make more red blood cells.
How should this medicine be used?
Darbepoetin alfa comes as a solution (liquid) to inject subcutaneously (just under the skin) or intravenously (into a vein). It is usually injected once a week every 1 to 3 weeks. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use darbepoetin alfa exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Your doctor may start you on the lowest possible dose of darbepoetin alfa and gradually increase or decrease your dose, not more than once every month. Your doctor may also tell you to stop using darbepoetin alfa for a time. Follow these instructions carefully. If your doctor tells you to stop using darbepoetin alfa, do not begin using it again until your doctor tells you that you should. It is likely that your doctor will restart your treatment with a lower dose of darbepoetin alfa than you were using.
Darbepoetin alfa is used to reduce the need for red blood cell transfusions. Darbepoetin alfa controls anemia but does not cure it. It may take 2 to 6 weeks or longer before you feel the full benefit of darbepoetin alfa Continue to use darbepoetin alfa even if you feel well. Do not stop using darbepoetin alfa without talking to your doctor.
Darbepoetin alfa injections are usually given by a doctor or nurse. Your doctor may decide that you can inject darbepoetin alfa yourself, or that you may have a friend or relative give the injections. Your doctor will train the person who will be injecting the medication and will test him to be sure he can give the injection correctly. Be sure that you and the person who will be giving the injections know the correct dose, how to give the medication, and how often to give the medication. Be sure that you and the person who will be giving the injections read the manufacturer's information for the patient that comes with darbepoetin alfa before you use it for the first time at home.
Darbepoetin alfa comes in prefilled syringes and also in vials to use with disposable syringes. Use vials and prefilled or disposable syringes only once. Do not put a needle through the rubber stopper of a vial more than once. Throw away a vial, syringe, or prefilled syringe after one use, even if it is not empty. Throw away used syringes in a puncture-resistant container, out of the reach of children. Do not throw a filled container into the household trash or recycling. Talk to your doctor or pharmacist about how to throw away the puncture-resistant container. There may be special state and local laws for throwing away used needles and syringes.
If you are using vials of darbepoetin alfa, you will need to use disposable syringes to inject your medication. Your doctor or pharmacist will tell you what type of syringe you should use. Do not use any other type of syringe because you may not get the right amount of medication.
Always inject darbepoetin alfa solution in its own syringe; never mix it with any other medication.
If you are injecting darbepoetin alfa subcutaneously, you can inject it just under the skin anywhere on these parts of your body: the outer area of your upper arms, your stomach except for the 2-inch area around your navel (belly button), the front of your middle thighs, and the upper outer areas of your buttocks.
Choose a new spot each time you inject darbepoetin alfa. Do not inject darbepoetin alfa into a spot that is tender, red, bruised, hard, lumpy, or swollen.
Carefully read the manufacturer's instructions that describe how to prepare and inject a dose of darbepoetin alpha. Be sure to ask your pharmacist or doctor if you have any questions about how to prepare or inject this medication.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using darbepoetin alfa,
- tell your doctor and pharmacist if you are allergic to darbepoetin alfa, epoetin alfa (Epogen, Procrit), medications made from animal cells, albumin, any other medications, latex, or polysorbate 80. Ask your doctor or pharmacist if you don't know if a medication you are allergic to is made from animal cells.
- tell your doctor if you have or have had high blood pressure. Your doctor may tell you not to use darbepoetin alfa.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.
- tell your doctor if you have or have ever had bleeding or blood clotting problems; diseases that affect your blood such as hemolytic anemia (condition where a low number of red blood cells occurs because the cells are being destroyed in the body); sickle cell disease (an inherited blood disease that causes pain, anemia, and organ damage), thalassemia (an inherited blood disease that causes abnormal development and other problems), or porphyria (an inherited blood disease that may cause skin or nervous system problems); blood clots in your heart, legs, or lungs; a heart attack; high blood pressure; stroke or ministroke (TIA); tumors; heart disease, or any disease that affects your brain or nervous system.
- tell your doctor if you have used darbepoetin alfa or another erythropoietic protein such as epoetin alfa (Epogen, Procrit) in the past. Be sure to tell your doctor if your anemia worsened during your treatment with one of these medications, or if you were ever told to stop using one of these medications.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using darbepoetin alfa, call your doctor.
- you should know that your blood pressure may increase while you are using darbepoetin alfa. Your doctor may ask you to check your blood pressure often. Be sure to check your blood pressure as often as your doctor tells you that you should, to call your doctor if your blood pressure is higher than your doctor says it should be, and to take any medications your doctor prescribes to control your blood pressure exactly as directed.
- you should call your doctor if you are planning to travel or if your activity becomes limited, such as spending more time sitting or in bed.
What special dietary instructions should I follow?
If you are following a prescribed special diet because you have kidney disease or high blood pressure, follow it carefully, even if you feel better while using darbepoetin alfa. Darbepoetin alfa will not work unless your body has enough iron. Your doctor or dietician will probably tell you to eat foods that are rich in iron. If you cannot get enough iron from your diet, your doctor may prescribe an iron supplement. Take this supplement exactly as directed.
What should I do if I forget a dose?
Call your doctor to ask what to do if you miss a dose of darbepoetin alfa. Do not use a double dose to make up for a missed one.
What side effects can this medication cause?
Darbepoetin alfa may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- headache
- nausea
- vomiting
- stomach pain
- diarrhea
- constipation
- body, joint, or muscle aches
- redness, swelling, bruising, itching, or a lump at the spot where you injected darbepoetin alfa
Some side effects can be serious. If you experience any of the following symptoms, or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- rash over the whole body
- itching
- difficulty breathing or swallowing
- wheezing
- hoarseness
- swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
- dry mouth
- sunken eyes
- decreased urination
- fever, sore throat, chills, cough, and other signs of infection
- feeling cold most of the time
- pale skin
Darbepoetin alfa may cause other side effects. Call your doctor if you have any unusual problems or you do not feel well while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the carton it came in, tightly closed, and out of reach of children. Once a vial or prefilled syringe has been taken out of its carton, keep it covered to protect it from room light until the dose is given. Store darbepoetin alfa in the refrigerator, but do not freeze it. Throw away any medication that has been frozen or is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
When traveling, pack darbepoetin alfa in its original carton in an insulated container with a coolant such as blue ice. To avoid freezing, make sure the darbepoetin alfa vial or prefilled syringe does not touch the coolant. Once you arrive, place darbepoetin alfa in a refrigerator as soon as possible.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- unusual tiredness, weakness, or lack of energy
- shortness of breath
- cough that won't go away, or coughing up blood
- wheezing
- dizziness or lightheadedness
- swelling around the mouth or eyes
- blue-grey coloring or darkening around mouth or nails
- fast or irregular heartbeat
- sweating
- seizure
- fainting or loss of consciousness
- chest pain, squeezing pressure, or tightness
- discomfort or pain in the arms, shoulder, neck, jaw, or back
- nausea
- vomiting
- sudden weakness or numbness of an arm or leg (especially on one side of the body) or face
- sudden confusion
- sudden trouble speaking or understanding speech
- sudden trouble seeing in one or both eyes
- sudden trouble walking, or loss of balance or coordination
- sudden severe headache
- pain, tenderness, redness, warmth, and/or swelling in the legs
- swelling of the hands, feet, or ankles
- increased blood pressure
- blood clot in hemodialysis access port
What other information should I know?
Before having any laboratory test, tell your doctor and the laboratory personnel that you are using darbepoetin alfa.
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
Ask Our Patient Community about Aranesp |
||
|
|
||
|
|
||